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Abstract: Heart rate variability (HRV) is a non-invasive indicator of autonomic nervous system
function. HRV recordings show artefacts due to technical and/or biological issues. The Kubios
software is one of the most used software to process HRV recordings, offering different levels of
threshold-based artefact correction (i.e., Kubios filters). The aim of the study was to analyze the impact
of different Kubios filters on the quantification of HRV derived parameters from short-term recordings
in three independent human cohorts. A total of 312 participants were included: 107 children with
overweight/obesity (10.0 ± 1.1 years, 58% men), 132 young adults (22.2 ± 2.2 years, 33% men) and 73
middle-aged adults (53.6 ± 5.2 years, 48% men). HRV was assessed using a heart rate monitor during
10–15 min, and the Kubios software was used for HRV data processing using all the Kubios filters
available (i.e., 6). Repeated-measures analysis of variance indicated significant differences in HRV
derived parameters in the time-domain (all p < 0.001) across the Kubios filters in all cohorts, moreover
similar results were observed in the frequency-domain. When comparing two extreme Kubios filters,
these statistical differences could be clinically relevant, e.g. more than 10 ms in the standard deviation
of all normal R-R intervals (SDNN). In conclusion, the results of the present study suggest that the
application of different Kubios filters had a significant impact on HRV derived parameters obtained
from short-term recordings in both time and frequency-domains.
Keywords: Kubios software; autonomic nervous system; data processing; children; young adults;
middle-aged adults
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1. Introduction
Heart rate variability (HRV) refers to the variation of the time interval between R peaks
(i.e., heartbeats) registered in an electrocardiogram (ECG) [1]. Previous studies have shown that a low
HRV at resting conditions reflects a low modulation of the parasympathetic branch on the sino-auricular
node [1,2], which is considered an indicator of cardiovascular and mortality risk [1–4]. Furthermore,
it has been previously reported that HRV decreases with ageing [5,6], especially in middle-aged adults
regardless of gender [6]. Beyond ECG, HRV can be estimated with certain heart rate monitors, which
makes the HRV assessment more feasible (i.e., less intrusive and economically affordable).
HRV recordings using heart rate monitors are affected by technical (e.g., wrong placement of
the heart rate monitor’s band) and/or biological (e.g., ectopic beats) artefacts. These artefacts could
contaminate the HRV recordings, making it difficult to obtain HRV derived parameters from long-term
(≈24 h) and especially short-term (≈5 min) recordings [1,7,8]. Artefacts could modify and produce
important over- or under-estimation of HRV derived parameters (up to 50%) [9]. Therefore, correction
of artefacts before the HRV assessment is needed for the accurate determination of HRV parameters
derived from short-term recordings.
Different commercially available software have been developed to process HRV raw data [10].
The Kubios software [11,12] is one of the most-frequently used in both clinical and research settings.
It allows the use of different threshold-based artefact correction filters (henceforth “Kubios filters”) [11].
The Kubios filter selection is usually based on subjective decisions since there is no consensus on
what is the most appropriate Kubios filter to process HRV raw data. To our knowledge, there is only
one study investigating the impact of different Kubios filters on the quantification of HRV derived
parameters from short-term recordings [13]. In this study, Aranda et al. showed that the selection of
the most restrictive filter had a noticeably impact on the quantification of HRV derived parameters
compared with the less restrictive filter in high-level professional athletes [13]. Since HRV depends
on a wide range of biological characteristics (e.g., age or body composition) [14], there is a need of
determining the impact of using different Kubios filters on HRV derived parameters estimation in
different populations [13]. Thus, this study aimed to analyze the impact of different Kubios filters on
the quantification of HRV derived parameters from short-term recordings in sedentary children with
overweight/obesity, sedentary young and sedentary middle-aged adults.
2. Experimental Section
2.1. Participants
The present study included baseline data from the ActiveBrains [15], the ACTIBATE [16] and
the FIT-AGEING [17] studies. A total of 312 participants were included in this cross-sectional study:
107 sedentary children (ActiveBrains) with overweight/obesity [15], 132 sedentary young adults
(ACTIBATE) [16] and, 73 sedentary middle-aged adults (FIT-AGEING) [17]. Detailed information
about the methodology, inclusion and exclusion criteria of the aforementioned studies can be found
elsewhere [15–17]. Briefly, the inclusion criteria were: (1) being physically inactive; (2) having a stable
body weight; (3) not being enrolled in a weight loss program; (4) not being a smokers; and (5) not
being pregnant.
All studies were conducted according to the Committee for Research Involving Human Subjects
at the University of Granada (References #848 and #924 for the ActiveBrains and ACTIBATE studies,
respectively), Servicio Andaluz de Salud (Centro de Granada, CEI-Granada for the ACTIBATE study) and
the Human Research Ethics Committee of the Junta de Andalucia (0838-N-2017) for the FIT-AGEING
study. All of them were performed in accordance with the Declaration of Helsinki (revision of 2013) and
registered in a specific clinical trial database (i.e., Clinicaltrial.gov. IDs: NCT02295072, NCT02365129
and NCT03334357 for the ActiveBrains, ACTIBATE and FIT-AGEING study, respectively). Both, oral
and written informed consent were obtained from all the participants and the children parents before
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their enrollment. Although the participants were enrolled in the aforementioned main studies, all of
them agreed to transfer their scientific data for other scientific purposes or research studies.
2.2. Heart Rate Variability Assessment
Participants came in the morning to the research centre by car or by bus, avoiding any physical
activity before the HRV assessment. Measurements took place between 8 AM and 12 PM for the
ActiveBrains study, and between 8 and 9 AM for both, the ACTIBATE and the FIT-AGEING studies.
Once in the research centre, participants lay on a bed or a stretcher in supine position equipped with a
Polar RS800CX heart rate monitor (Polar Electro Oy Inc., Kempele, Finland) in a quiet room with dim
lighting (for all the studies), and controlled ambient temperature and humidity (for the ACTIBATE
and the FIT-AGEING studies). Heart rhythm was recorded during 10–15 min (sampling frequency of
1000 Hz). Before such a recording, participants were instructed to breathe normally, and not to talk,
fidget, or sleep while measurements were being taken (Figure 1). Of note, the Polar RS800CX heart
rate monitor has been validated against electrocardiography, and also has been proved as a reliable
equipment in the assessment of HRV in both children [18,19] and adults [20,21].
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Figure 1. Study design. HRV: heart rate variability. None (A), Very Low (B), Low (C), Medium (D), 
Strong (E) and Very Strong (F) filters refers  to  the  level of threshold‐based artefact correction (i.e., 
Kubios  filter). Graphs  are  examples  of  the  same  best  5 min  period  (of  the whole  heart  rhythm 
recoding)  that met  the  selection  criteria  after  using different Kubios  filters. RR: R‐R  intervals;  S: 
seconds; min: minutes. 
2.3. Heart Rate Variability Data Processing 
For the HRV data processing we used the Kubios software (v.3.0.0, HRV analysis, University of 
Eastern Finland) [11,12]. The best 5 min period of the whole heart rhythm recording was manually 
selected by one evaluator based on the following criteria: (1) Gaussians R‐R intervals and heart rate 
distribution graphs; (2) no large R‐R interval outliers; and (3) R‐R intervals equidistance [22–24]. The 
R‐R intervals series were detrended using the smoothness prior method with alpha set at 500. 
All Kubios  filter  levels  (i.e.,  threshold‐based  artefact  correction; Figure  1) were used  on  the 
selected 5‐min periods [25]. The Kubios filter algorithm compares every R‐R interval value against a 
local average interval [25]. The local average interval is procured by median filtering the R‐R interval 
time series, and therefore, the local average is not influenced by outliers R‐R intervals. Thus, if the R‐
R interval varies from the local average interval more than a specified threshold value, the interval is 
Figure 1. Study design. HRV: heart rate variability. None (A), Very Low (B), Low (C), Medium (D),
Strong (E) and Very Strong (F) filters refers to the level of threshold-based artefact correction (i.e., Kubios
filter). Graphs are examples of the same best 5 min period (of the whole heart rhythm recoding) that
met the selection criteria after using different Kubios filters. RR: R-R intervals; S: seconds; min: minutes.
2.3. Heart Rate Variability Data Processing
For the HR d ta processing we used the Kubios software (v.3.0.0, HRV analysis, University of
Eastern Finland) [11,12]. The best 5 min period of the whole heart rhythm recording was manually
selected by one evaluator based on the following criteria: (1) Gaussians R-R intervals and heart rate
distribution graphs; (2) no large R-R interval outliers; and (3) R-R intervals equidistance [22–24]. The
R-R intervals series were detrended using the smoothness prior method with alpha set at 500.
All Kubios filt r levels (i.e., threshold-based artefact cor ection; Figure 1) were used on the selected
5-min periods [25]. The Kubios filter algorithm comp res ev ry R-R nterval value against a local
average interval [25]. The local average in val is procured by median filtering the R-R interval time
series, nd th refo e, the local average is not influenced by outliers R-R int vals. Thus, if the R-R
interval varies from the local average interval more than a specified threshold value, the interval is
designated as an artefact and marked for correction by the software [25]. The available Kubios filters
are: (1) None (no correction is performed; Figure 1A), (2) Very Low (0.45 s; Figure 1B), (3) Low (0.35;
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Figure 1C), (4) Medium (0.25 s; Figure 1D), (5) Strong (0.15 s; Figure 1E) and, (6) Very Strong (0.05 s;
Figure 1F) [25]. For example, if a Very Low Kubios filter is used, the software marks for correction all
R-R intervals that are 0.45 s larger or smaller than the local average interval. Then, these artefacts are
subsequently interpolated using a cubic spline interpolation.
In the present study, we considered the most-frequently used HRV derived parameters from
short-term recordings in both time and frequency domains. In the time-domain, we computed (1) the
standard deviation of all normal R-R intervals (SDNN) in milliseconds (ms), (2) the squared root of the
mean of the sum of the squares of successive normal R–R interval differences (RMSSD) in ms, and (3) the
number of pairs of adjacent normal R-R intervals differing by more than 50 ms in the entire recording
(pNN50) expressed as percentage. Regarding the frequency-domain, we derived (1) the power in the
high frequency (HF: 0.15–0.4 Hertz (Hz)), (2) the power in the low frequency (LF: 0.04–0.15 Hz), and (3)
the power in the very low frequency (VLF: 0–0.04 Hz) using the fast Fourier transformation algorithm
(FFT), all expressed in absolute units (ms2). The LF/HF ratio was also calculated.
2.4. Anthropometric Assessment
We measured the participants’ height and body weight without shoes and with light clothing
using a Seca scale (model 799, Electronic Column Scale, Hamburg, Germany) and a stadiometer. Body
mass index (BMI) was calculated as body weight (kg) divided by square height (m2). Children were
classified as children with overweight/obesity accordingly to the World Obesity Federation sex-and-age
specific international BMI standards [26]. Waist circumference was measured twice, in a standing
position, and using a plastic tape at the midpoint between the costal margin and iliac crest in the
mid-axillary line [27]. The average of both measurements was used.
2.5. Statistical Analysis
Descriptive data are presented as means ± standard deviation or frequency and percentages
as appropriate. Normality of the HRV derived parameters in time- and frequency-domains were
tested using Kolmogorov-Smirnov test and visual inspection of histograms. Although HRV derived
parameters did not exhibit a normal distribution, for analytical purposes we did not transform them.
Repeated-measure analyses of variance (ANOVA) were used to test differences in HRV derived
parameters in time- and frequency-domains across the different Kubios filters (i.e., None, Very Low, Low,
Medium, Strong and Very Strong). Analyses were replicated with the non-parametric Friedman test
and similar results were found, and therefore, only ANOVA results are reported. Bonferroni corrections
were used for post-hoc comparisons. Analyses were conducted using the Statistical Package for Social
Sciences (SPSS, v. 22.0, IBM SPSS Statistics, IBM Corporation, Chicago, IL, USA). The significance level
was set at 0.05.
3. Results
The descriptive characteristics of the participants are presented in Table 1. The percentages of
R-R intervals interpolated during the whole recording and during the selected best 5 min period for
data analysis are shown in Table 2. The mean of interpolated R-R intervals across studies were 0.3,
0.7, 1.6, 4.9 and 29.9% when the Very Low, Low, Medium, Strong and Very Strong filters were used
respectively (Table 2). Moreover, we performed a visual inspection of the R-R signals (Figure S1) for
detecting possible premature contractions (characterized by short-long R-R intervals, i.e. coupling
interval and compensatory pause) and we did not observe premature contractions in the most of the
R-R signals based on the observer criteria.
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Table 1. Descriptive data of the participants.
Children (n = 107) Young Adults (n = 132) Middle-Aged Adults (n = 73)
n % n % n %
Sex
Male 60 57.1 43 32.6 35 47.9
Female 45 42.9 89 67.4 38 52.1
Mean ± SD Mean ± SD Mean ± SD
Age (years) 10 ± 1 22 ± 2 54 ± 5
Body mass index (kg/m2) 26.9 ± 3.7 25.0 ± 4.8 26.7 ± 3.8
Waist circumference (cm) 90.2 ± 9.9 81.6 ± 14.6 95.0 ± 11.8
Data are presented as mean and standard deviation (SD) unless otherwise stated.
Table 2. Percentage of R-R intervals interpolated in the heart rate variability (HRV) measurements
when using different Kubios filter.
Children (n = 107) Young Adults (n = 132) Middle-Aged Adults (n = 73)
Mean ± SD Min Max Mean ± SD Min Max Mean ± SD Min Max
Beats corrected (%)
During the whole measurement (10–15 min)
None 0.0 ± 0.0 0.0 0.0 0.0 ± 0.0 0.0 0.0 0.0 ± 0.0 0.0 0.0
Very Low 0.8 ± 1.7 0.0 11.8 0.2 ± 0.7 0.0 5.3 0.1 ± 0.1 0.0 0.8
Low 1.6 ± 2.6 0.0 15.5 0.4 ± 1.1 0.0 5.4 0.1 ± 0.2 0.0 1.0
Medium 3.4 ± 4.4 0.0 20.9 1.3 ± 2.7 0.0 15.6 0.1 ± 0.4 0.0 2.8
Strong 9.0 ± 9.2 0.0 36.9 5.2 ± 6.9 0.0 35.4 0.8 ± 1.7 0.0 9.3
Very Strong 41.0 ± 18.1 1.9 76.6 35.0 ± 17.2 1.1 74.8 14.9 ± 11.5 0.06 45.7
During the selected period (5 min)
None 0.0 ± 0.0 0.0 0.0 0.0 ± 0.0 0.0 0.0 0.0 ± 0.0 0.0 0.0
Very Low 0.7 ± 1.8 0.0 11.6 0.1 ± 0.7 0.0 7.7 0.1 ± 0.3 0.0 1.5
Low 1.5 ± 3.0 0.0 17.9 0.4 ± 1.1 0.0 7.7 0.2 ± 0.8 0.0 5.2
Medium 3.2 ± 5.0 0.0 25.3 1.2 ± 2.7 0.0 17.1 0.4 ± 1.5 0.0 8.8
Strong 8.5 ± 9.7 0.0 39.6 4.5 ± 7.1 0.0 36.1 1.7 ± 4.4 0.0 21.0
Very Strong 39.4 ± 19.3 1.0 77.2 33.1 ± 18.8 0.0 75.5 17.1 ± 15.8 0.0 60.8
Data are presented as mean and standard deviation (SD), minimum (Min) and maximum (Max).
Figure 2 shows mean and standard deviation values of SDNN, RMSSD and pNN50 for every
cohort across the different Kubios filters. Significant differences were observed in mean SDNN
(Figure 2A,D,G), mean RMSSD (Figure 2B,E,H) and mean pNN50 (Figure 2C,F,I) across Kubios filters
in all cohorts (all p < 0.001). Significant differences were observed after post-hoc Bonferroni corrections
in both children and young adults (Figure 2A–F). Mean SDNN, mean RMSSD and mean pNN50 were
similar across Kubios filters in middle-aged adults except when the Very Strong filter was compared
with the other Kubios filters (Figure 2G,H,I).
Figure 3 shows mean and standard deviation values of frequency-domain HRV derived parameters
across different Kubios filters, showing similar results to those in time-domain parameters. Significant
differences were observed in mean HF (all p < 0.025; Figure 3A,E,I) and mean LF (all p < 0.038;
Figure 3B,F,J) across filters in the three cohorts. Significant differences were also found in the LF/HF
ratio across different Kubios filters in children and young adults (all p < 0.001; Figure 3C,G), whereas
no differences were noted in middle aged adults (p = 0.794; Figure 3K). Likewise, significant differences
were observed in the VLF in children and in middle-aged adults (all p < 0.008; Figure 3D,L). Although
repeated-measures ANOVA showed no differences in VLF across different Kubios filters in young
adults (p = 0.233; Figure 3H), significant post-hoc differences were observed (Figure 3).
We repeated the ANOVA model to test differences in HRV derived parameters in time- and
frequency-domains excluding the Very Strong Kubios filter, and the results remained similar (Figure
S2 and Figure S3). Moreover, in deeper analyses we observed that the Very Strong filter equalizes HRV
among the study participants although the differences between the cohorts still remained significant
(Figure S4, Figure S5 and Figure S6).
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Figure 2. Differences on the Heart Rate Variability (HRV) time-domain parameters using different
Kubios filters in three different cohorts. Data are represented as mean and standard deviation. SDNN:
standard deviation of all normal R–R intervals (Panels A, D and G); RMSSD: squared root of the
mean of the sum of the squares of successive normal R–R interval differences (Panels B, E and H);
pNN50: number of pairs of adjacent normal R–R intervals differing by more than 50ms in the entire
recording (Panels C, F and I); p value from the ANOVA comparisons; similar letters means Bonferroni
post-hoc differences.
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inspection before HRV analysis did not detect artefacts or premature contractions in the most of the 
R‐R interval signals visually inspected. 
Several studies have reported the importance of artefact correction on the quantification of HRV 
derived  parameters  from  short‐term  recordings  [8,28,29].  However,  there  is  scarce  evidence 
regarding  the  impact  of  using  different  Kubios  filters  on  the  quantification  of  HRV  derived 
Figure 3. Differences on the Heart Rate Variability (HRV) frequency-domain parameters using different
Kub os filter in th e different coho s. Data re represented as m an and sta dard d viation. HF:
power in the high freque cy (in absolute units, ms2; P nels A, E an I); LF: power in the low frequency
(in absolute units, ms2; Panels B, F and J); LF/HF: ratio of the power in the low frequency divided
by the power in the high frequency (Panels C, G and K); VLF: power in the very low frequency (in
absolute units, ms2; Panels D, H and L). p value from the ANOVA comparisons; similar letters means
Bonferroni post-hoc differences.
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4. Discussion
The present study showed that the application of certain Kubios filters had a significant impact
on the quantification of HRV derived parameters obtained from short-term recordings in time and
frequency-domains in sedentary children with overweight/obesity, sedentary young and sedentary
middle-aged adults. Our results also suggest that children and young adults’ recordings were more
affected by lower intensity Kubios filters (i.e., Very Low, Low and Medium) than middle-aged adults.
Thus, potential artefacts could be corrected or interpolated with Kubios filters of lower intensity in
children and in young adults. The Very Strong filter should be used with caution, given that the
interpolated R-R intervals were 39% (from 1% to 77.2%) in children, 33% (from 0 to 75.5%) in young
adults, and 17% (from 0 to 60.8%) in middle-aged adults in the selected best 5 min period, which means
that most of the selected period is “artificial” (i.e., interpolated) in younger populations. Furthermore,
after the visual inspection of the R-R signals in children, young adults and middle-aged adults we did
not visually find any premature contractions based on the observer criteria. However, we do not have
ECG tracings to verify whether “real” artefacts happened or not. Therefore, we cannot exclude that the
high number of interpolated R-R intervals using the Very Strong filter could be related to either the
Very Strong filter has some problem of excessive sensitivity or the heart rate monitor used for HRV
assessment creates an excess of artefacts that are detected only by the Very Strong filter. Nevertheless,
the former option is very likely since children and young adults usually present high sinus rhythm
fluctuations resulting in big differences between consecutive R-R intervals which may be “overfiltered”
by the Kubios filters. This is even more possible because the visual inspection before HRV analysis did
not detect artefacts or premature contractions in the most of the R-R interval signals visually inspected.
Several studies have reported the importance of artefact correction on the quantification of HRV
derived parameters from short-term recordings [8,28,29]. However, there is scarce evidence regarding
the impact of using different Kubios filters on the quantification of HRV derived parameters from
short-term recordings in time- and frequency-domains employing the commercially available Kubios
software [10]. The selection of the Kubios filter has been usually performed subjectively. While some
studies have selected and reported the use of a Low or Medium Kubios filters for the same cohort,
others did not report the filter employed. Based on the results of the current study, it should be
mandatory to explicitly acknowledge which Kubios filter is used in order to ease comparability of
HRV derived parameters among different studies.
To the best of our knowledge, there is only one study testing the impact of the application of
different Kubios filters on the quantification of the HRV derived parameters obtained by short-term
recordings [13]. Aranda et al. [13] found that the use of a Very Strong filter (compared to the others filters)
significantly affected the quantification of HRV derived parameters in time- and frequency-domains in
30 professional athletes. These findings concur with ours, and in fact we observed a significant impact
on HRV derived parameters in time- and frequency-domains among the Kubios filters even using the
Very Low, the Low, the Medium and the Strong filters (see Figures 2 and 3). Despite the participants of
the Aranda et al. study [13] were young adults (25 ± 3 years old), the different results obtained between
studies could be explained by the training status (professional athletes vs. sedentary), methodological
factors such as the body positioning during the HRV assessment (sitting vs. lying), or the heart rate
monitor employed for the HRV recordings (Firstbeat Bodyguard vs. Polar RS800CX).
The clinical relevance of the observed differences on the HRV derived parameters should be
considered. SDNN in resting conditions is considered a good indicator of cardiovascular and mortality
risk [1]. Indeed, a previous study has reported that each increase of 10 ms in SDNN could indicate a
reduction of ≈20% in the risk of mortality in adults with ischemic cardiomyopathy [30]. Comparing
the SDNN values after the application of two similar Kubios filters in our study (the Very Low filter
vs. the Low filter), we observed a mean SDNN difference of 3.66 ms, 1.16 ms and 0.08 ms in children,
young and middle-aged adults. Therefore, these differences between filters might not have a clinically
relevant impact. However, when extreme Kubios filters were compared (i.e., the Very Low filter vs. the
Very Strong filter), we observed a mean SDNN difference of 38.68 ms, 27.25 ms and 7.83 ms in children,
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young and middle-aged adults. These mean SDNN differences between filters likely represent a clinical
relevancy difference on both children and young adults, considering the aforementioned 10 ms in
SDNN suggesting a reduction on the risk of mortality. Of note, the clinical relevancy mentioned should
be considered with caution as some important differences need to be acknowledged: the cohorts of
the study (adults with cardiovascular diseases vs. children, young and middle-aged adults without
cardiovascular diseases), the length and instrument employed during the HRV assessment (24 h Holter
vs. 10–15 min Polar RS800CX heart rate monitor). Furthermore, in practice, could be inappropriate
to compare SDNN values because the total variance of HRV increases with the duration of the HRV
recording [1].
The Kubios user’s guide recommends a percentage of interpolated R-R intervals lower than 5%.
The software developers argue that this percentage should be enough to remove artefacts avoiding an
excessive interpolation of R-R intervals. To our knowledge, this recommendation has not been tested in
large and/or different cohorts. Moreover, they suggested that the Kubios filter should be individually
selected to account for inter-individual variability in the HRV. Based on our results, we suggested the
use a lower intensity Kubios filter (i.e. Very Low, Low or Medium filters) in younger populations,
while a stronger Kubios filter could be used in older populations (with caution when using the Very
Strong Kubios filter) to achieve the manufacturer’ recommendation of less than 5% of R-R intervals
interpolated to remove HRV recordings artefacts (see Table 2). We also observed that the Very Strong
filter highly reduces the HRV, because by definition, it must exclude every R-R interval which is 50ms
longer or shorter than the local average R-R interval. Thus, the Very Strong filter equalizes the HRV
among the study participants (Figure S4, Figure S5 and Figure S6).
The design of the current study precludes providing definitive thresholds and future studies
are needed testing those recommendations. Moreover, we do not know whether Kubios filters
remove “real” artefacts or large prolongations of R-R interval which may appear in healthy young
individuals. Therefore, for Kubios software users, it is important to choose a reasonable filtering
level (e.g., with caution when using the Very Strong Kubios filter), and hence, this study may have
practical implications. Indeed, the kind of filter should correspond to the quality of the data, e.g., data
collected during exercises or daily activity will need stronger filters than those recorded at rest. In
addition, according to the results of our study, one should also consider the age of subjects before
choosing the appropriate filter. Furthermore, we would recommend to the Kubios software users to
apply different filters and to perform sensitivity analyses in order to study the effect of a treatment
“X” on the HRV derived parameters. Thus, the Kubios software users might have a higher confident
level in their results because are not “filter dependent” (i.e., their results are consistent across different
Kubios filters).
We are aware of some limitations in our study: (1) the children cohort included in the present study
was a sample of sedentary children with overweight/obesity, so we cannot extrapolate our findings to
normal-weight children, (2) the experimental conditions during the HRV assessment were not exactly
the same in the three different studies (e.g., the hour and/or dates of the HRV assessments), (3) the HRV
assessment was performed once per participant during a relatively short period (10–15 min), and (4)
we did not employ ECG tracings to verify whether “real” artefacts happened or not, thus our results
could be influenced by the fact that we have used a polar RS800CX. Therefore, future studies should
be performed using other alternatives tools (e.g., a different heart rate monitor or ECG) to confirm
whether the impact of the different Kubios filters remained independently of the tool employed for
recording the heart rhythm. On the other hand, the strengths of our study were: (1) a large sample size;
(2) the impact of different Kubios filters was tested in three different and independent human cohorts;
(3) all R-R interval signals have been visually inspected to detect obvious artefacts; and, (4) the HRV
derived parameters were obtained from short-term recordings, which are increasing their popularity
in both clinical and research context due their relative ease in data collection and management.
J. Clin. Med. 2020, 9, 325 9 of 11
5. Conclusions
The results of the present study suggest that the application of different Kubios filters had
a significant impact on the quantification of HRV derived parameters obtained from short-term
recordings in both time and frequency-domains in children, young and middle-aged adults. Moreover,
reporting the filter employed should be mandatory to allow comparisons across studies. Although the
design of the current study precludes providing definitive thresholds, we suggested to use a Very Low,
Low or Medium filter in children and young adults, whereas any Kubios filter (with caution when
using the Very Strong Kubios filter) may be employed for middle-aged adults, when the processing
of the short-terms HRV recordings is performed using the commercially available Kubios software.
Further studies are guaranteed in order to elucidate which are the best Kubios filters to obtain valid
data of HRV derived parameters.
Supplementary Materials: The following are available online at http://www.mdpi.com/2077-0383/9/2/325/s1,
Figure S1: Example of a visual inspection of a R-R signal to find possible artefacts or premature contractions across
Kubios filters; Figures S2 and S3: Differences on the Heart Rate Variability (HRV) time- and frequency-domains
parameters respectively without considering the Very Strong filter; Figure S4: Differences between cohorts on the
SDNN using different Kubios filters; Figure S5: Differences between cohorts on the pNN50 using different Kubios
filters; and Figure S6: Differences between cohorts on the HF using different Kubios filters.
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